Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The three things that actually moved operator risk
If you run a treatment center, three developments from early 2025 will move your enterprise value, your payer contracts, and your survey exposure for the rest of the year: a platform M&A restart led by Oceans Healthcare’s acquisition of Haven Behavioral Healthcare, the January 1 applicability of the 2024 Mental Health Parity Final Rule (later paused by federal regulators on May 15), and a Department of Justice enforcement posture pointed squarely at behavioral health billing. Everything else on the January news cycle is noise.
January opened with Oceans closing on Haven. The deal added seven behavioral health hospitals and outpatient services across Arizona, Idaho, Ohio, New Mexico and Pennsylvania, taking Oceans to 48 facilities across nine states, supported by a workforce of approximately 4,000 employees. Days later, Iris Telehealth announced it had acquired innovaTel from Quartet Health on January 21. Four weeks. Two platform deals worth watching. That was the starting gun.
The M&A picture: platforms are back, and buyers got smarter
Use the numbers. Oceans’ network jumped to 48 facilities across nine states after the Haven close, and platform interest visibly reset in the first month of the year. If you own a single-site or small multi-site asset in Florida, Texas, Pennsylvania, or the Carolinas, two things are true. Buyers are calling. And the buyers who are calling have gotten a lot more disciplined about what they will pay for.
Read the market signal carefully. If your medical records will not survive a serious clinical due diligence read, if your payer mix is fragile, or if your Joint Commission or CARF file has open findings, buyers will bucket you as distressed regardless of top-line growth. Iris Telehealth CEO Andy Flanagan told Behavioral Health Business that Iris was not bringing on an “unprofitable” company and that his company is always focused on “responsible” growth. Translation for operators: quality of earnings and clinical documentation get you a premium. Everything else gets diligenced down.
One more number worth memorizing before your next diligence call. FBI Director Kash Patel said the 2025 Takedown had uncovered “more than $13 billion in fraud” and called it the largest for the initiative to date. Every buyer’s model is reading that headline. Medicaid enforcement risk now lands directly in diligence questions, and it will show up in the data room long before it shows up in your P&L.
The 2024 Parity Final Rule went live, then the Departments paused enforcement
On September 9, 2024, the Departments of Labor, HHS, and Treasury issued the 2024 Final Rule under MHPAEA, with staggered applicability for plan years starting on or after January 1, 2025 and January 1, 2026. That was the calendar operators were staring at on January 2, 2025. Then, on January 17, 2025, the ERISA Industry Committee (ERIC) filed suit against the Departments, arguing the rule exceeded MHPAEA authority.
On May 15, 2025, the Departments issued a formal non-enforcement statement. The Departments will not enforce the 2024 Final Rule or otherwise pursue enforcement actions, based on a failure to comply that occurs prior to a final decision in the litigation, plus an additional 18 months. Here is the part operators keep misreading. This enforcement relief applies only with respect to those portions of the 2024 Final Rule that are new in relation to the 2013 final rule, and MHPAEA’s statutory obligations, as amended by the CAA, 2021, continue to have effect.
Epstein Becker Green attorneys read it the same way: the 2013 MHPAEA rules remain in effect, as does plans’ obligation to develop comparative analyses of non-quantitative treatment limits (“NQTLs”). Your NQTL comparative analysis obligation did not go away. Neither did state parity enforcement in Florida, Ohio, Texas, or Pennsylvania. The federal non-enforcement policy does not apply to state regulators, who interpret and enforce both federal and state laws for mental health parity. If your utilization management denials, medical necessity criteria application, or ASAM Criteria 4th Edition level-of-care determinations look asymmetric versus how your payers handle medical-surgical benefits, you are still exposed. State insurance departments are not standing down, and payers still ask for parity documentation during network contracting and SIU audits.
Federal enforcement: behavioral health is squarely in the crosshairs
If you thought fraud enforcement would soften under a new administration, look at the numbers DOJ actually reported. Settlements and judgments under the False Claims Act exceeded $6.8 billion in the fiscal year ending Sept. 30, 2025, and that amount is the highest in a single year in the history of the False Claims Act. Of the more than $6.8 billion, over $5.7 billion related to matters that involved the health care industry. Whistleblowers filed 1,297 qui tam lawsuits, the highest number in a single year.
Deputy Attorney General Todd Blanche put it plainly: “Stopping rampant fraud is a top priority, and this record-breaking year proves the False Claims Act remains one of the government’s most powerful weapons against fraud.”
Behavioral health is not a bystander. The 2025 National Health Care Fraud Takedown charged 324 defendants across 50 federal districts and 12 State Attorneys General’s Offices for their alleged participation in various health care fraud schemes involving over $14.6 billion in intended loss, and the government seized over $245 million in cash, luxury vehicles, cryptocurrency, and other assets. Cases named in the Takedown reached behavioral health providers directly, including matters in the Eastern District of Virginia and the District of Arizona.
The number operators keep sleeping on is a payment-side number. CMS announced that it successfully prevented over $4 billion from being paid in response to false and fraudulent claims and that it suspended or revoked the billing privileges of 205 providers in the months leading up to the Takedown. Payment stops before charges land. DOJ paired the announcement with a new Health Care Fraud Data Fusion Center that will pull together cloud computing, artificial intelligence, and analytics resources across DOJ’s Criminal Division, HHS-OIG, FBI, and DEA. If your documentation does not match your billing, someone is already looking.
What operators should actually do in the first quarter
Stop reading the news. Look at your own file. Here is the short list an operator should run through this week.
- Diligence-readiness audit. Even with zero intent to sell, treat your pro forma, payer mix, chart audit sample, and licensure and accreditation file as if a strategic buyer’s diligence team lands Monday. Operators with EBITDA between $3 million and $10 million fit the exact profile PE platforms are hunting, and the offer will come whether you invited it or not.
- NQTL parity file. Confirm you have a current comparative analysis on hand for every payer contract, even during the federal non-enforcement window. State regulators and payer SIU audit teams are still asking, and the CAA 2021 statutory obligation remains in force.
- Billing and documentation match. Pull a random 30-chart sample. Compare what was billed to what was documented for medical necessity, level of care, and time-based codes. If the sample fails, expand the audit before someone else does it for you.
- ASAM Criteria 4th Edition alignment. Confirm your clinical leadership has moved level-of-care determinations onto the current edition. Payers have. Your documentation should match.
- Compliance program, not compliance binder. A compliance program that lives in a shared drive gets you a finding. A compliance program that lives in your weekly operating cadence gets you through a survey window.
The January 2, 2025 news cycle looked like deals and rules. It was really a starting gun on a year where operators with clean books, clean charts, and a real compliance program get paid, and everyone else gets diligenced out of a deal or investigated into one.
Frequently asked questions
Is the 2024 Mental Health Parity Final Rule still in effect for behavioral health providers?
Partly. The 2024 Final Rule was not rescinded, but on May 15, 2025 the Departments of Labor, HHS, and Treasury announced they will not enforce the portions of the rule that are new relative to the 2013 rule until a final decision in the ERIC litigation, plus an additional 18 months. MHPAEA’s statutory obligations, as amended by the Consolidated Appropriations Act, 2021, continue to have effect, including the NQTL comparative analysis requirement. State insurance departments were encouraged to adopt a similar approach, but many continue to enforce state parity laws independently.
How exposed is my treatment center to federal fraud enforcement in 2025 and 2026?
Meaningfully more exposed than two years ago. DOJ reported False Claims Act settlements and judgments exceeding $6.8 billion in fiscal year 2025, the largest annual recovery in the statute’s history, with over $5.7 billion tied to healthcare and 1,297 qui tam suits filed. The 2025 National Health Care Fraud Takedown charged 324 defendants across 50 federal districts with schemes involving over $14.6 billion in intended loss, and CMS separately suspended or revoked billing privileges of 205 providers in the months leading up to the Takedown. Operators should treat documentation-to-billing alignment and medical necessity substantiation as board-level risk items.
Do I still need an NQTL comparative analysis if the federal government is not enforcing the 2024 rule?
Yes. The requirement to develop and maintain nonquantitative treatment limitation comparative analyses comes from the Consolidated Appropriations Act, 2021, not from the 2024 Final Rule. The Departments’ May 15, 2025 statement was explicit that MHPAEA’s statutory obligations as amended by CAA 2021 remain in effect and that the 2013 MHPAEA final rule remains in force. State insurance departments and payer SIU audit teams continue to request these analyses during contracting, credentialing, and audits.
What are private equity buyers actually looking for in behavioral health deals right now?
Quality of earnings, clean clinical documentation, diversified payer mix, and current licensure and accreditation files. Iris Telehealth CEO Andy Flanagan framed his January 2025 acquisition of innovaTel around not taking on an unprofitable company and focusing on responsible growth. Platforms typically target EBITDA between $3 million and $10 million with defensible margins. Operators with open Joint Commission or CARF findings, thin payer mixes, or documentation gaps will be diligenced into a distressed bucket regardless of top-line growth.
References
- Oceans Healthcare Acquires Haven Behavioral Healthcare, Inc. (PRNewswire, Jan 2, 2025)
- Oceans Healthcare press release on Haven acquisition
- Iris Telehealth Acquires innovaTel from Quartet Health (Behavioral Health Business, Jan 21, 2025)
- DOL/HHS/Treasury Statement on Enforcement of the 2024 MHPAEA Final Rule (May 15, 2025)
- Epstein Becker Green: What Non-Enforcement of the 2024 Parity Rule Means for Employer Plans
- Groom Law Group: Departments Pause Enforcement of MHPAEA Final Rule
- Quarles: Departments Will Not Enforce 2024 Final Rule under MHPAEA
- DOJ: False Claims Act Settlements and Judgments Exceed $6.8B in Fiscal Year 2025
- DOJ: 2025 National Health Care Fraud Takedown (324 defendants, $14.6B intended loss)
- DEA: 2025 National Health Care Fraud Takedown (FBI Director Patel statement)